These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 17331619

  • 1. In vitro activities of tachyplesin III against Pseudomonas aeruginosa.
    Cirioni O, Giacometti A, Kamysz W, Silvestri C, Riva A, Della Vittoria A, Abbruzzetti A, Lukasiak J, Scalise G.
    Peptides; 2007 Apr; 28(4):747-51. PubMed ID: 17331619
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain.
    Cirioni O, Ghiselli R, Silvestri C, Kamysz W, Orlando F, Mocchegiani F, Di Matteo F, Riva A, Lukasiak J, Scalise G, Saba V, Giacometti A.
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2005-10. PubMed ID: 17403995
    [Abstract] [Full Text] [Related]

  • 3. Synergistic and antibiofilm properties of ocellatin peptides against multidrug-resistant Pseudomonas aeruginosa.
    Bessa LJ, Eaton P, Dematei A, Plácido A, Vale N, Gomes P, Delerue-Matos C, Sa Leite JR, Gameiro P.
    Future Microbiol; 2018 Feb; 13():151-163. PubMed ID: 29308671
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients.
    Giacometti A, Cirioni O, Kamysz W, D'Amato G, Silvestri C, Licci A, Nadolski P, Riva A, Lukasiak J, Scalise G.
    Int J Antimicrob Agents; 2005 Sep; 26(3):235-40. PubMed ID: 16122911
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes.
    Simonetti O, Ganzetti G, Arzeni D, Campanati A, Marconi B, Silvestri C, Cirioni O, Gabrielli E, Lenci I, Kamysz W, Kamysz E, Giacometti A, Scalise G, Barchiesi F, Offidani A.
    Peptides; 2009 Oct; 30(10):1794-7. PubMed ID: 19591887
    [Abstract] [Full Text] [Related]

  • 6. In vitro synergism of beta-lactams with ciprofloxacin and moxifloxacin against genetically distinct multidrug-resistant isolates of Pseudomonas aeruginosa.
    Kanellakopoulou K, Sarafis P, Galani I, Giamarellou H, Giamarellos-Bourboulis EJ.
    Int J Antimicrob Agents; 2008 Jul; 32(1):33-9. PubMed ID: 18538547
    [Abstract] [Full Text] [Related]

  • 7. In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa.
    Pankey GA, Ashcraft DS.
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2959-64. PubMed ID: 15980375
    [Abstract] [Full Text] [Related]

  • 8. In vitro activities of various antibiotics, alone and in combination with colistin methanesulfonate, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
    Güzel CB, Gerçeker AA.
    Chemotherapy; 2008 Jul; 54(2):147-51. PubMed ID: 18322363
    [Abstract] [Full Text] [Related]

  • 9. Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis.
    Cirioni O, Ghiselli R, Kamysz W, Orlando F, Silvestri C, Mocchegiani F, Di Matteo F, Kamysz E, Riva A, Rocchi M, Saba V, Scalise G, Giacometti A.
    Peptides; 2008 Jan; 29(1):31-8. PubMed ID: 18068869
    [Abstract] [Full Text] [Related]

  • 10. Searching for new strategies against biofilm infections: Colistin-AMP combinations against Pseudomonas aeruginosa and Staphylococcus aureus single- and double-species biofilms.
    Jorge P, Grzywacz D, Kamysz W, Lourenço A, Pereira MO.
    PLoS One; 2017 Jan; 12(3):e0174654. PubMed ID: 28355248
    [Abstract] [Full Text] [Related]

  • 11. Experimental Induction of Bacterial Resistance to the Antimicrobial Peptide Tachyplesin I and Investigation of the Resistance Mechanisms.
    Hong J, Hu J, Ke F.
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6067-75. PubMed ID: 27480861
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of synergistic activity of bovine lactoferricin with antibiotics in corneal infection.
    Oo TZ, Cole N, Garthwaite L, Willcox MD, Zhu H.
    J Antimicrob Chemother; 2010 Jun; 65(6):1243-51. PubMed ID: 20375033
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
    Aoki N, Tateda K, Kikuchi Y, Kimura S, Miyazaki C, Ishii Y, Tanabe Y, Gejyo F, Yamaguchi K.
    J Antimicrob Chemother; 2009 Mar; 63(3):534-42. PubMed ID: 19147523
    [Abstract] [Full Text] [Related]

  • 14. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Lee MY, Ko KS, Song JH, Peck KR.
    J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
    [Abstract] [Full Text] [Related]

  • 15. In vitro synergistic activity of colistin and ceftazidime or ciprofloxacin against multidrug-resistant clinical strains of Pseudomonas aeruginosa.
    D'Souza BB, Padmaraj SR, Rekha PD, Tellis RC, Prabhu S, Pothen P.
    Microb Drug Resist; 2014 Dec; 20(6):550-4. PubMed ID: 25055029
    [Abstract] [Full Text] [Related]

  • 16. Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa.
    Chin JN, Jones RN, Sader HS, Savage PB, Rybak MJ.
    J Antimicrob Chemother; 2008 Feb; 61(2):365-70. PubMed ID: 18079128
    [Abstract] [Full Text] [Related]

  • 17. In vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin-1b (Esc 1-18) in combination with conventional antibiotics against Stenotrophomonas maltophilia.
    Maisetta G, Mangoni ML, Esin S, Pichierri G, Capria AL, Brancatisano FL, Di Luca M, Barnini S, Barra D, Campa M, Batoni G.
    Peptides; 2009 Sep; 30(9):1622-6. PubMed ID: 19520127
    [Abstract] [Full Text] [Related]

  • 18. Synergistic interactions between mammalian antimicrobial defense peptides.
    Yan H, Hancock RE.
    Antimicrob Agents Chemother; 2001 May; 45(5):1558-60. PubMed ID: 11302828
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection.
    Giacometti A, Cirioni O, Kamysz W, Silvestri C, Licci A, Riva A, Łukasiak J, Scalise G.
    Peptides; 2005 Nov; 26(11):2111-6. PubMed ID: 16269345
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of antimicrobial combinations against multidrug-resistant Pseudomonas aeruginosa.
    Santos DA, Nascimento MM, Vitali LH, Martinez R.
    Rev Soc Bras Med Trop; 2013 Nov; 46(3):299-303. PubMed ID: 23856877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.